NYSE: ABBV
Healthcare · Drug Manufacturers - General
Market Cap
$365.43B
52w High
$244.81
52w Low
$176.57
P/E
100.71
Volume
5.34M
Outstanding Shares
1.77B
Price vs Fundamentals
The stock rose 6.86% over the last year. Revenue grew 9.5% over the trailing twelve months. Operating margin moved from 17.56% to 27.6%. Free cash flow grew 4.87% over the trailing twelve months.
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 27.6%. A decisive move in revenue — currently up 9.5% — would be the clearest signal to resolve the ambiguity.
Company profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
28
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 30, 2026
Q3 FY26 · EPS est $3.73 · Revenue est $16.78B
View
Dividends
$6.74/shareQuarterlyDividend Achiever · 12yrAt RiskABBV pays a dividend with a 3.26% dividend yield, 12 consecutive years of growth, growing at 6.33% annually, covered 1.5× by free cash flow.
Dividend Yield
3.26%
Annual Div / Share
$6.74
5yr CAGR
+6.33%
Doubles every ~11.3yr
Payout Ratio
320.34%
At Risk
Dividend Growth Rate
3yr CAGR
+5.26%
5yr CAGR
+6.33%
10yr CAGR
+12.05%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$3/mo
In 5 yrs
$4/mo
In 10 yrs
$5/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$33/yr $3/mo | $44/yr+36% $4/mo | $60/yr+85% $5/mo |
Yield-on-cost grows from 3.26% → 6.02% over 10yr
Analysis
Dividend Achiever
ABBV has raised its dividend for 12 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 1.5× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 6.33% meaningfully outpaces inflation, compounding real income growth for long-term holders.
High payout ratio
With 320.34% of earnings paid as dividends, there is limited retained earnings for reinvestment — and a dividend cut becomes more likely if earnings decline.